[Non-interventional study of metastatic castration-resistant prostate cancer. Prospective, non-interventional trial on the influence of adherence to abiraterone treatment in patients with metastatic, castrate-resistant prostate cancer (IMPACT) - trial AP 76/13 of the AUO].

Authors	H Rexer
Journal	Der Urologe. Ausg. A (Urologe A) Vol. 54 Issue 7 Pg. 1021-2 (Jul 2015) ISSN: 1433-0563 [Electronic] Germany
Vernacular Title	Nicht-interventionelle Studie beim metastasierten, kastrationsresistenten Prostatakarzinom. Prospektive, nicht-interventionelle Studie zum Einfluss von Adhärenzmaßnahmen auf die Therapie von Abirateron bei Patienten mit metastasiertem, kastrationsresistentem Prostatakarzinom (IMPACT) - Studie AP 76/13 der AUO.
PMID	26162276 (Publication Type: Journal Article, Multicenter Study, Observational Study)
Chemical References	Androstenes Antineoplastic Agents abiraterone
Topics	Administration, Oral Androstenes (administration & dosage) Antineoplastic Agents (administration & dosage) Carcinoma (diagnosis, drug therapy, epidemiology, secondary) Germany (epidemiology) Humans Male Medication Adherence (statistics & numerical data) Prevalence Prospective Studies Prostatic Neoplasms, Castration-Resistant (diagnosis, drug therapy, epidemiology) Risk Factors Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!